{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T00:54:51Z","timestamp":1768697691053,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81430101"],"award-info":[{"award-number":["81430101"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014175","name":"Shanghai Municipal Health and Family Planning Commission","doi-asserted-by":"publisher","award":["ZYBZ-2017028"],"award-info":[{"award-number":["ZYBZ-2017028"]}],"id":[{"id":"10.13039\/501100014175","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014175","name":"Shanghai Municipal Health and Family Planning Commission","doi-asserted-by":"publisher","award":["CCCX-4003"],"award-info":[{"award-number":["CCCX-4003"]}],"id":[{"id":"10.13039\/501100014175","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Integrative Medicine"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.joim.2020.05.003","type":"journal-article","created":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T22:18:24Z","timestamp":1590617904000},"page":"319-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Comparable effects of Jiedu Granule, a compound Chinese herbal medicine, and sorafenib for advanced hepatocellular carcinoma: A prospective multicenter cohort study"],"prefix":"10.1016","volume":"18","author":[{"given":"He-tong","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-bin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-feng","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin-bin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sha-sha","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Man","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui-xia","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu-ying","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun-ke","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-quan","family":"Ling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.joim.2020.05.003_b0005","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.joim.2020.05.003_b0010","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.joim.2020.05.003_b0015","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"issue":"11","key":"10.1016\/j.joim.2020.05.003_b0020","doi-asserted-by":"crossref","first-page":"18296","DOI":"10.18632\/oncotarget.15433","article-title":"Tumor stage and primary treatment of hepatocellular carcinoma at a large tertiary hospital in China: a real-world study","volume":"8","author":"Zhong","year":"2017","journal-title":"Oncotarget"},{"issue":"18","key":"10.1016\/j.joim.2020.05.003_b0025","doi-asserted-by":"crossref","first-page":"30471","DOI":"10.18632\/oncotarget.12887","article-title":"Jie-du granule preparation for the treatment of advanced hepatocellular carcinoma: a retrospective cohort study of 177 patients","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.joim.2020.05.003_b0030","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00535-019-01642-1","article-title":"REFLECT\u2014a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset","volume":"55","author":"Yamashita","year":"2020","journal-title":"J Gastroenterol"},{"issue":"9","key":"10.1016\/j.joim.2020.05.003_b0035","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.4254\/wjh.v7.i9.1209","article-title":"Traditional Chinese medicine for prevention and treatment of hepatocarcinoma: from bench to bedside","volume":"7","author":"Hu","year":"2015","journal-title":"World J Hepatol"},{"issue":"1","key":"10.1016\/j.joim.2020.05.003_b0040","doi-asserted-by":"crossref","first-page":"4355","DOI":"10.1038\/s41598-017-04351-y","article-title":"A systematic review and meta-analysis of traditional insect Chinese medicines combined chemotherapy for non-surgical hepatocellular carcinoma therapy","volume":"7","author":"Shi","year":"2017","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.joim.2020.05.003_b0045","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1111\/liv.12847","article-title":"Adjunctive traditional Chinese medicine therapy improves survival of liver cancer patients","volume":"35","author":"Liao","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.joim.2020.05.003_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.152930","article-title":"Effects of adjuvant traditional Chinese medicine therapy on long-term survival in patients with hepatocellular carcinoma","volume":"62","author":"Liu","year":"2019","journal-title":"Phytomedicine"},{"issue":"28","key":"10.1016\/j.joim.2020.05.003_b0055","doi-asserted-by":"crossref","first-page":"45234","DOI":"10.18632\/oncotarget.16804","article-title":"Transarterial chemoembolization combined with Jie-du Granule preparation improves the survival outcomes of patients with unresectable hepatocellular carcinoma","volume":"8","author":"Zhao","year":"2017","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.joim.2020.05.003_b0060","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1002\/cncr.30915","article-title":"Traditional herbal medicine prevents postoperative recurrence of small hepatocellular carcinoma: a randomized controlled study","volume":"124","author":"Zhai","year":"2018","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.joim.2020.05.003_b0065","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3736\/jintegrmed2013021","article-title":"Traditional herbal medicine in preventing recurrence after resection of small hepatocellular carcinoma: a multicenter randomized controlled trial","volume":"11","author":"Zhai","year":"2013","journal-title":"J Integr Med"},{"key":"10.1016\/j.joim.2020.05.003_b0070","doi-asserted-by":"crossref","first-page":"5629304","DOI":"10.1155\/2018\/5629304","article-title":"The Chinese medicine, Jiedu Recipe, inhibits the epithelial mesenchymal transition of hepatocellular carcinoma via the regulation of Smad2\/3 dependent and independent pathways","volume":"2018","author":"Liang","year":"2018","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.joim.2020.05.003_b0075","unstructured":"Ministry of Health of the People\u2019s Republic of China. Updated standards for the diagnosis and treatment of primary liver cancer. Zhonghua Gan Zang Bing Za Zhi 2012; 20(6): 419\u201326 [Chinese]."},{"issue":"6","key":"10.1016\/j.joim.2020.05.003_b0080","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.joim.2020.05.003_b0085","doi-asserted-by":"crossref","unstructured":"Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45(2): 228\u201347.","DOI":"10.1016\/j.ejca.2008.10.026"},{"issue":"3","key":"10.1016\/j.joim.2020.05.003_b0090","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S1053-4296(03)00031-6","article-title":"CTCAE v3. 0: development of a comprehensive grading system for the adverse effects of cancer treatment","volume":"13","author":"Trotti","year":"2003","journal-title":"Semin Radiat Oncol"},{"issue":"2","key":"10.1016\/j.joim.2020.05.003_b0095","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.rdc.2018.01.002","article-title":"Propensity score methods for bias reduction in observational studies of treatment effect","volume":"44","author":"Johnson","year":"2018","journal-title":"Rheum Dis Clin North Am"},{"issue":"11","key":"10.1016\/j.joim.2020.05.003_b0100","doi-asserted-by":"crossref","first-page":"799","DOI":"10.4254\/wjh.v10.i11.799","article-title":"Role of traditional Chinese medicine in the management of patients with hepatocellular carcinoma","volume":"10","author":"Xi","year":"2018","journal-title":"World J Hepatol"},{"issue":"5","key":"10.1016\/j.joim.2020.05.003_b0105","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11655-012-1083-1","article-title":"Preventive effects of Jiedu granules combined with Cinobufacini Injection versus transcatheter arterial chemoembolization in post-surgical patients with hepatocellular carcinoma: a case-control trial","volume":"18","author":"Chen","year":"2012","journal-title":"Chin J Integr Med"},{"issue":"22","key":"10.1016\/j.joim.2020.05.003_b0110","doi-asserted-by":"crossref","first-page":"5132","DOI":"10.1002\/cncr.24567","article-title":"The efficacy for unresectable hepatocellular carcinoma may be improved by transcatheter arterial chemoembolization in combination with a traditional Chinese herbal medicine formula: a retrospective study","volume":"115","author":"Yu","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.joim.2020.05.003_b0115","unstructured":"Zhao HT, Lu JY, Du J. Anti-tumor effects of Jiedu granule preparation on H22 tumor-bearing mice. Liaoning Zhong Yi Za Zhi 2018; 45(1): 186\u20139 [Chinese with abstract in English]."},{"issue":"2","key":"10.1016\/j.joim.2020.05.003_b0120","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3350\/kjhep.2011.17.2.113","article-title":"Applicability of the BCLC staging system to patients with hepatocellular carcinoma in Korea: analysis at a single center with a liver transplant center","volume":"17","author":"Kim","year":"2011","journal-title":"Korean J Hepatol"},{"issue":"5","key":"10.1016\/j.joim.2020.05.003_b0125","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jhep.2008.09.001","article-title":"Sorafenib in advanced hepatocellular carcinoma\u2014we have won a battle not the war","volume":"49","author":"Galle","year":"2008","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.joim.2020.05.003_b0130","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S1470-2045(08)70285-7","article-title":"Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial","volume":"10","author":"Cheng","year":"2009","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.joim.2020.05.003_b0135","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00535-005-1566-3","article-title":"Updated treatment approach to hepatocellular carcinoma","volume":"40","author":"Llovet","year":"2005","journal-title":"J Gastroenterol"},{"issue":"4","key":"10.1016\/j.joim.2020.05.003_b0140","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"issue":"10126","key":"10.1016\/j.joim.2020.05.003_b0145","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.joim.2020.05.003_b0150","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12906-019-2806-z","article-title":"Problems lowering the study quality in traditional medicine, introspection from an example of meta-analysis of acupuncture","volume":"20","author":"Chen","year":"2020","journal-title":"BMC Complement Med Ther"},{"issue":"19","key":"10.1016\/j.joim.2020.05.003_b0155","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1002\/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B","article-title":"Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group","volume":"17","author":"D\u2019Agostino","year":"1998","journal-title":"Stat Med"},{"key":"10.1016\/j.joim.2020.05.003_b0160","series-title":"Current research in acupuncture","first-page":"687","article-title":"Future research in acupuncture: better design and analysis for novel and valid findings","author":"Asakawa","year":"2013"}],"container-title":["Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095496420300558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2095496420300558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:48:28Z","timestamp":1761864508000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2095496420300558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S2095496420300558"],"URL":"https:\/\/doi.org\/10.1016\/j.joim.2020.05.003","relation":{},"ISSN":["2095-4964"],"issn-type":[{"value":"2095-4964","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparable effects of Jiedu Granule, a compound Chinese herbal medicine, and sorafenib for advanced hepatocellular carcinoma: A prospective multicenter cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Integrative Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.joim.2020.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Shanghai Changhai Hospital. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}